Security
Aesther Healthcare Acquisition Corp Class A Common Stock · AEHA
AEHANASDAQCommon stockHistorical · closed Feb 14, 2023CIK 1869974Updated Nov 16, 2026
AEHA price & chart
This listing closed Feb 14, 2023. Live provider charts are shown only for current listings.
Current security: OCEA
In the news
No coverage from other publishers is available.
Recent filings
NT 10-Q filing
25-NSE - filed by Nasdaq Stock Market LLC regarding Ocean Biomedical, Inc.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other Events
Items 3.01, 5.02, 8.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Items 3.01
Termination of a Material Definitive Agreement
Items 1.02
Show 5 more recent filings
Termination of a Material Definitive Agreement
Items 1.02
10-Q filing
10-K/A filing
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other Events
Items 3.01, 5.02, 8.01, 9.01
10-K filing
Financials
FY 2024 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2024 | Q3 2023 | Q3 2022 | Q2 2024 | Q2 2023 | Q1 2025 | Q1 2024 | Q1 2023 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 1,132,000Source | 1,031,000Source | 109,128,586Source | 1,851,000Source | 2,161,000Source | 1,582,000Source | 2,946,000Source | 306,000Source | 902,000Source | 5,501,000Source | 110,911,324Source | 108,652,342Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Assets, CurrentUSD | 1,042,000Source | 1,031,000Source | 599,607Source | 1,277,000Source | 2,161,000Source | 1,492,000Source | 1,799,000Source | 306,000Source | 812,000Source | 2,109,000Source | 467,989Source | 1,549,893Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 99,217,000Source | 76,255,000Source | 5,241,168Source | 94,594,000Source | 63,818,000Source | 93,981,000Source | 78,729,000Source | 55,059,000Source | 98,518,000Source | 96,264,000Source | 6,613,855Source | 3,396,444Source |
| Stockholders’ equity: | ||||||||||||
| Additional Paid in CapitalUSD | 107,733,000Source | 103,975,000Source | -2,330,265Source | 107,547,000Source | 103,455,000Source | 121,376,000Source | 107,273,000Source | 98,928,000Source | 107,919,000Source | 105,292,000Source | -3,380,265Source | -1,280,265Source |
| Retained Earnings (Accumulated Deficit)USD | -205,818,000Source | -179,199,000Source | -2,311,569Source | -200,290,000Source | -165,112,000Source | -213,775,000Source | -183,056,000Source | -153,681,000Source | -205,535,000Source | -196,055,000Source | -2,765,874Source | -564,110Source |
| Stockholders' Equity Attributable to ParentUSD | -98,085,000Source | -75,224,000Source | -9,836,000Source | -92,743,000Source | -61,657,000Source | -92,399,000Source | -75,783,000Source | -54,753,000Source | -97,616,000Source | -90,763,000Source | -6,145,866Source | -1,844,102Source |
| Liabilities and EquityUSD | 1,132,000Source | 1,031,000Source | 109,128,586Source | 1,851,000Source | 2,161,000Source | 1,582,000Source | 2,946,000Source | 306,000Source | 902,000Source | 5,501,000Source | 110,911,324Source | 108,652,342Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 33,649,000Source | 30,851,000Source | 2,091,168Source | 30,738,000Source | 29,787,000Source | 26,568,000Source | 30,109,000Source | 23,747,000Source | 33,889,000Source | 30,012,000Source | 3,463,855Source | 246,444Source |
| Accounts Payable, CurrentUSD | 16,570,000Source | 16,048,000Source | 181,035Source | 17,180,000Source | 14,509,000Source | 16,387,000Source | 16,880,000Source | 15,751,000Source | 15,899,000Source | 16,185,000Source | 324,829Source | 34,444Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | — | 804,000Source | 860,133Source | — | 764,000Source | — | — | 927,000Source | — | 946,000Source | 989,026Source | 212,000Source |
cash flow · annual statements
| Line item | Q4 2024 | Q4 2023 | Q3 2024 | Q3 2023 | Q2 2024 | Q2 2023 | Q1 2025 | Q1 2024 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | — | — | — | — | 290,385Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -356,000Source | -485,000Source | -4,180,000Source | -9,429,000Source | -747,297Source |
| Cash flows from investing activities: | |||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | — | — | — | -2,100,000Source |
| Cash flows from financing activities: | |||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | — | — | — | 12,676,000Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 909,000Source | — | 3,400,000Source | 10,399,000Source | 2,100,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 553,000Source | -485,000Source | -780,000Source | 970,000Source | -747,297Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 200,000Source | 1,000,000Source | 200,000Source | 1,100,000Source | 800,000Source | — | 200,000Source | 1,000,000Source | — |
| Additional Financial Items | |||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 186,000Source | 186,000Source | 187,000Source | 186,000Source | 186,000Source | 186,000Source | 745,000Source | 1,205,000Source | — |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | -126,000Source | 570,000Source | -331,000Source | -1,159,000Source | 269,000Source | -1,005,000Source | -1,469,000Source | 1,171,000Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | -224,000Source | — | -903,000Source | — | — | — | -15,080,000Source | — |
| General and Administrative ExpenseUSD | — | — | 768,000Source | 2,350,000Source | 682,000Source | 2,804,000Source | 940,000Source | 569,000Source | 3,772,000Source | 9,505,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -5,528,000Source | -14,087,000Source | -17,234,000Source | -11,431,000Source | -8,240,000Source | 12,999,000Source | -9,480,000Source | -114,466,000Source | -958,430Source |
| Nonoperating Income (Expense)USD | — | — | -4,760,000Source | -11,432,000Source | -16,552,000Source | -8,599,000Source | -7,282,000Source | 13,594,000Source | -5,682,000Source | -104,252,000Source | — |
| Operating ExpensesUSD | — | — | 768,000Source | 2,655,000Source | 682,000Source | 2,832,000Source | 958,000Source | 595,000Source | 3,798,000Source | 10,214,000Source | — |
| Other Nonoperating Income (Expense)USD | — | — | — | -3,000Source | — | — | — | — | — | -1,000Source | — |
| Payments to Acquire InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | 2,100,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | 14,260,000Source | — |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | — | —Source | — | — | — | — | — | — | — |
| Share-based Payment Arrangement, Noncash Expense | — | — | — | — | — | — | —Source | —Source | — | — | — |
| InterestExpenseNonoperating | — | — | — | — | — | — | —Source | —Source | — | — | — |
income statement · annual statements
| Line item | Q4 2024 | Q4 2023 | Q3 2024 | Q3 2023 | Q2 2024 | Q2 2023 | Q1 2025 | Q1 2024 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | -768,000Source | -2,655,000Source | -682,000Source | -2,832,000Source | -958,000Source | -595,000Source | -3,798,000Source | -10,214,000Source | -16,121,000Source |
| Other Nonoperating Income (Expense)USD | — | — | — | -3,000Source | — | — | — | — | — | -1,000Source | 5,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -5,528,000Source | -14,087,000Source | -17,234,000Source | -11,431,000Source | -8,240,000Source | 12,999,000Source | -9,480,000Source | -114,466,000Source | -17,359,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.2Source | -0.53Source | -0.63Source | -0.43Source | -0.09Source | 0.48Source | -0.34Source | -4.35Source | -0.74Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.2Source | -0.53Source | -0.63Source | -0.43Source | -0.09Source | 0.48Source | -0.34Source | -4.35Source | -0.74Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 27,487,283Source | 26,605,147Source | 27,487,283Source | 26,469,619Source | 91,024,268Source | 27,344,486Source | 27,502,537Source | 26,292,438Source | 23,355,432Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 27,487,283Source | 26,605,147Source | 27,487,283Source | 26,469,619Source | 91,024,268Source | 27,344,486Source | 27,502,537Source | 26,292,438Source | 23,355,432Source |
| Additional Financial Items | |||||||||||
| Business Combination, Acquisition Related CostsUSD | — | — | — | — | — | — | — | — | — | 7,578,000Source | — |
| General and Administrative ExpenseUSD | — | — | 768,000Source | 2,350,000Source | 682,000Source | 2,804,000Source | 940,000Source | 569,000Source | 3,772,000Source | 9,505,000Source | 7,712,000Source |
| Interest ExpenseUSD | — | — | — | 0Source | — | 24,046Source | — | — | — | 50,000Source | — |
| Interest Income (Expense), NetUSD | — | — | -461,000Source | -293,000Source | -515,000Source | -668,000Source | — | -637,000Source | -2,046,000Source | -1,762,000Source | -1,243,000Source |
| Nonoperating Income (Expense)USD | — | — | -4,760,000Source | -11,432,000Source | -16,552,000Source | -8,599,000Source | -7,282,000Source | 13,594,000Source | -5,682,000Source | -104,252,000Source | -1,238,000Source |
| Operating ExpensesUSD | — | — | 768,000Source | 2,655,000Source | 682,000Source | 2,832,000Source | 958,000Source | 595,000Source | 3,798,000Source | 10,214,000Source | 16,121,000Source |
| Research and Development ExpenseUSD | — | — | — | 305,000Source | — | 28,000Source | 18,000Source | 26,000Source | 26,000Source | 709,000Source | 8,409,000Source |
| Interest Expense (non-operating) | — | — | — | — | — | — | —Source | —Source | — | — | — |
| Other Income | — | — | — | — | — | —Source | — | — | — | — | — |
Filing attachments
ex99-1.htm · 8-K · 2025-04-23
EX-99.1 2 ex99-1.htm Exhibit 99.1 Ocean Biomedical Expands into Energy and Digital Asset Sectors to Accelerate Growth and Shareholder Value April 22, 2025 08:00 ET | Source: Ocean Biomedical, Inc. Follow Strategic diversification into power infrastructure and cryptocurrencies supports long-term biopharma innovation PROVIDENCE, R.I., April 22, 2025 (GLOBE NEWSWIRE) - Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on pioneering treatments for cancer, infectious d…
Read attachment ↗